Multidrug resistance protein and topoisomerase 2 alpha expression in non-small cell lung cancer are related with brain metastasis postoperatively.

The aim of this study was to investigate association between expressions of multidrug resistance protein (MRP) and topoisomerase 2 alpha expression in non-small cell lung cancer (TOP2A) and brain metastasis operatively. The expression of MRP and TOP2A were performed using immunohistochemistry (IHC) staining, and the results were analyzed in correlation with clinicopathological data. A total of 286 NSCLC patients who underwent curative surgery between 2007 and 2013 were enrolled in this study. Positive expression of MRP and TOP2A were 62.2% and 37.8%. MRP positive expression in NSCLC was significantly correlated with tumor cell differentiation (P=0.028). TOP2A expression was significantly associated with patients' smoking status, tumor histological type (P<0.05). The positive MRP group had significantly inferior survival rates for 2-year BMFS than did the negative MRP group (79.0% vs. 93.4%, P=0.003) by the Kaplan-Meier method and a log-rank test. Similarly, the positive TOP2A expression was inversely correlated with 2-year BMFS (84.2% vs. 93.4%, P=0.030). Multivariate analysis showed that gender, MRP expression and TOP2A expression were independent prognostic factors for BMFS (P<0.05). Positive expressions of MRP and TOP2A in the tumor tissue are associated with increased risk of developing brain metastases in NSCLC.

[1]  Changxing Shen,et al.  Overexpression of adenylate cyclase-associated protein 1 may predict brain metastasis in non-small cell lung cancer. , 2015, Oncology reports.

[2]  Yuemao Shen,et al.  Topoisomerase IIα, rather than IIβ, is a promising target in development of anti-cancer drugs. , 2012, Drug discoveries & therapeutics.

[3]  G. Pasternak,et al.  The role of multidrug resistance‐associated protein in the blood–brain barrier and opioid analgesia , 2013, Synapse.

[4]  G. Melloni,et al.  Combined treatment of non-small cell lung cancer with synchronous brain metastases: a single center experience. , 2011, The Journal of cardiovascular surgery.

[5]  W. Berger,et al.  Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications , 2005, Journal of Cancer Research and Clinical Oncology.

[6]  F. Yang,et al.  The impact of Caspase-8 on non-small cell lung cancer brain metastasis in II/III stage patient. , 2015, Neoplasma.

[7]  F. Gao,et al.  Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines. , 2011, Oncology reports.

[8]  Zj Chen,et al.  Lung Resistance Protein and Multidrug Resistance Protein in Non-Small Cell Lung Cancer and Their Clinical Significance , 2011, The Journal of international medical research.

[9]  D. Miller,et al.  Surgical treatment of primary lung cancer with synchronous brain metastases. , 2001, The Journal of thoracic and cardiovascular surgery.

[10]  G. Giaccone,et al.  Topoisomerase IIα and other drug resistance markers in advanced non-small cell lung cancer , 2001 .

[11]  M. Sonobe,et al.  Prognostic factors for patients in postoperative brain metastases from surgically resected non-small cell lung cancer , 2014, International Journal of Clinical Oncology.

[12]  Liancong Wang,et al.  Positive expression of p53, c-erbB2 and MRP proteins is correlated with survival rates of NSCLC patients. , 2013, Molecular and clinical oncology.

[13]  U. Abacıoğlu,et al.  Who may benefit from prophylactic cranial irradiation amongst stage III non-small cell lung cancer patients? , 2013, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[14]  Chen Li,et al.  Topoisomerase II alpha expression and the benefit of adjuvant chemotherapy for postoperative patients with non-small cell lung cancer , 2010, BMC Cancer.

[15]  Jun Liang,et al.  Risk factors for brain metastases in locally advanced non-small cell lung cancer with definitive chest radiation. , 2014, International journal of radiation oncology, biology, physics.

[16]  A. Twijnstra,et al.  Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma , 2002, Cancer.

[17]  Moon Soo Kim,et al.  A nomogram to predict brain metastasis as the first relapse in curatively resected non-small cell lung cancer patients. , 2015, Lung cancer.